Systemic antibiotic sales and WHO recommendations, India

Aashna Mehta,Petra Brhlikova,Patricia McGettigan,Allyson M Pollock,Peter Roderick,Habib Hasan Farooqui
DOI: https://doi.org/10.2471/BLT.22.287908
IF: 13.831
2022-10-04
Bulletin of the World Health Organization
Abstract:CONCLUSION: The sale of Watch group drugs, and antibiotics banned or not approved, needs active investigation and enforcement in India. The evidence base underpinning formal approvals and no-objection certificates for not-recommended fixed-dose combinations should be audited.
public, environmental & occupational health
What problem does this paper attempt to address?